Evidence map›Paper›PMID 42782351›Full record

ArticleJournal of neural transmission (Vienna, Austria : 1996)2026

Pain characteristics in isolated cervical dystonia: comparison to orthopedic cervical conditions and assessment of botulinum toxin effects.

L Vorbeck, L Herrmann, A Palisi, S Lezius, A Maurer, M Dreimann, M Gelderblom, J Mallwitz, Simone Zittel

Abstract readComparative Study
In one paragraph

Article in Journal of neural transmission (Vienna, Austria : 1996), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

L Vorbeck *Department of Neurology, Institute for Applied Physiology, University of Ulm, Ulm, Germany.
L Herrmann *Department of Neurology, Institute for Applied Physiology, University of Ulm, Ulm, Germany.
A PalisiRückenzentrum am Michel, Hamburg, Germany.
S LeziusInstitute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
A MaurerDepartment of Neurology, Institute for Applied Physiology, University of Ulm, Ulm, Germany.
M DreimannDepartment of Trauma Surgery and Orthopedics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
M GelderblomDepartment of Neurology, Institute for Applied Physiology, University of Ulm, Ulm, Germany.
J MallwitzRückenzentrum am Michel, Hamburg, Germany.
Simone ZittelDepartment of Neurology, Institute for Applied Physiology, University of Ulm, Ulm, Germany. s.zittel-dirks@uke.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective was to characterize pain and evaluate quality of life (QoL) in cervical dystonia (CD) by comparing pain profiles with patients affected by orthopedic cervical conditions (OCC) and evaluating differences between CD patients with and without head tremor (HT). Additionally, longitudinal changes after botulinum toxin (BoNT) treatment in CD were assessed. Pain is the most prevalent non-motor symptom in CD. However, its clinical characteristics and underlying mechanisms are incompletely understood. Isolated CD and OCC patients were evaluated regarding pain characteristics and QoL using self-report questionnaires. CD patients additionally underwent blinded motor assessment and were stratified according to the presence of HT. A subset of CD patients was reevaluated 4-6 weeks after BoNT treatment. 49 CD patients and 49 OCC patients were investigated. The overall pain profile was comparable between CD and OCC; only nociceptive pain perception was higher in OCC than in CD. HT in CD patients was associated with increased nociceptive pain and greater QoL impairment. Following BoNT injection in CD, pain and QoL improved significantly. The marked similarities of pain profiles in CD and OCC together with the increased nociceptive pain in CD patients with HT suggest that musculoskeletal mechanisms contribute to pain in CD. Improvement of pain and QoL in CD patients with long disease duration after BoNT treatment indicates the relevant effect on non-motor symptoms. Further studies are needed to clarify the underlying pathophysiology of pain in CD.

Indexed as

Botulinum ToxinsBotulinum Toxins, Type ANeuromuscular AgentsPainTorticollisAdultAgedFemaleHumansMaleMiddle AgedPain MeasurementQuality of LifeTremorBotulinum ToxinsBotulinum Toxins, Type ANeuromuscular AgentsCervical dystoniaHead tremorNociceptive painPainQuality of life

Identifiers

PMID42782351
PMCPMC13687203

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.